Literature DB >> 14695625

Glycophorin C (Gerbich antigen blood group) and band 3 polymorphisms in two malaria holoendemic regions of Papua New Guinea.

Sheral S Patel1, Christopher L King, Charles S Mgone, James W Kazura, Peter A Zimmerman.   

Abstract

The geographic overlap between the prevalence of erythrocyte polymorphisms and malaria endemicity is thought to be an example of natural selection on human populations. In Papua New Guinea (PNG), the Gerbich-negative phenotype is caused by an exon 3 deletion in the glycophorin C gene (GYPCDeltaex3) while heterozygosity for a 27-base pair deletion in the SLC4A1 gene (anion exchanger 1 or erythrocyte membrane protein, band 3), SLC4A1Delta27, results in Southeast Asian ovalocytosis. Two geographically and ethnically distinct malaria endemic regions of PNG (the Wosera [East Sepik Province] and Liksul [Madang Province]) were studied to illustrate the distribution of two prominent deletion polymorphisms (GYPCDeltaex3 and SLC4A1Delta27) and to determine if the genetic load associated with SLC4A1Delta27 would constrain independent assortment of GYPCDeltaex3 heterozygous and homozygous genotypes. The frequency of the GYPCDeltaex3 allele was higher in the Wosera (0.463) than Liksul (0.176) (chi(2); P < 0.0001). Conversely, the frequency of the SLC4A1Delta27 allele was higher in Liksul (0.0740) than the Wosera (0.0005) (chi(2); P < 0.0001). No individuals were homozygous for SLC4A1Delta27. In 355 Liksul residents, independent assortment of these two deletion polymorphisms resulted in 14 SLC4A1Delta27 carriers heterozygous for GYPCDeltaex3 and one SLC4A1Delta27 carrier homozygous for GYPCDeltaex3 (Fisher's exact test; P = 0.8040). While homozygosity for SLC4A1Delta27 appears to be nonviable, the GYPCDeltaex3 allele is not lethal when combined with SLC4A1Delta27. Neither mutation was associated with altered susceptibility to asymptomatic Plasmodium falciparum or P. vivax infection. While these erythrocyte polymorphisms apparently have no effect on blood-stage malaria infection, their contribution to susceptibility to clinical malaria morbidity requires further study. Copyright 2003 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 14695625      PMCID: PMC3728820          DOI: 10.1002/ajh.10448

Source DB:  PubMed          Journal:  Am J Hematol        ISSN: 0361-8609            Impact factor:   10.047


  22 in total

Review 1.  Genetic variability in response to infection: malaria and after.

Authors:  D J Weatherall; J B Clegg
Journal:  Genes Immun       Date:  2002-09       Impact factor: 2.676

2.  The role of red blood cell polymorphisms in resistance and susceptibility to malaria.

Authors:  B Lell; J May; R J Schmidt-Ott; L G Lehman; D Luckner; B Greve; P Matousek; D Schmid; K Herbich; F P Mockenhaupt; C G Meyer; U Bienzle; P G Kremsner
Journal:  Clin Infect Dis       Date:  1999-04       Impact factor: 9.079

Review 3.  Common genetic disorders of the red cell and the 'malaria hypothesis'.

Authors:  D J Weatherall
Journal:  Ann Trop Med Parasitol       Date:  1987-10

4.  Human erythrocyte glycophorin C. Gene structure and rearrangement in genetic variants.

Authors:  Y Colin; C Le Van Kim; A Tsapis; M Clerget; L d'Auriol; J London; F Galibert; J P Cartron
Journal:  J Biol Chem       Date:  1989-03-05       Impact factor: 5.157

5.  The association of the glycophorin C exon 3 deletion with ovalocytosis and malaria susceptibility in the Wosera, Papua New Guinea.

Authors:  S S Patel; R K Mehlotra; W Kastens; C S Mgone; J W Kazura; P A Zimmerman
Journal:  Blood       Date:  2001-12-01       Impact factor: 22.113

6.  The Gerbich blood group system, especially in Melanesians.

Authors:  P B Booth; K McLoughlin
Journal:  Vox Sang       Date:  1972-01       Impact factor: 2.144

7.  Rearrangements of the red-cell membrane glycophorin C (sialoglycoprotein beta) gene. A further study of alterations in the glycophorin C gene.

Authors:  S High; M J Tanner; E B Macdonald; D J Anstee
Journal:  Biochem J       Date:  1989-08-15       Impact factor: 3.857

8.  Red cell antigen, serum protein and red cell enzyme polymorphisms in Karkar Islanders and inhabitants of the adjacent North Coast of New Guinea.

Authors:  P B Booth; D Tills; A Warlow; A C Kopeć; A E Mourant; P Teesdale; R W Hornabrook
Journal:  Hum Hered       Date:  1982       Impact factor: 0.444

9.  Malaria infections are randomly distributed in diverse holoendemic areas of Papua New Guinea.

Authors:  Rajeev K Mehlotra; Laurin J Kasehagen; Moses Baisor; Kerry Lorry; James W Kazura; Moses J Bockarie; Peter A Zimmerman
Journal:  Am J Trop Med Hyg       Date:  2002-12       Impact factor: 2.345

10.  Age-acquired immunity to a Plasmodium vivax invasion ligand, the duffy binding protein.

Authors:  Jennifer L Cole-Tobian; Alfred Cortés; Moses Baisor; Will Kastens; Jia Xainli; Moses Bockarie; John H Adams; Christopher L King
Journal:  J Infect Dis       Date:  2002-07-26       Impact factor: 5.226

View more
  16 in total

Review 1.  How malaria has affected the human genome and what human genetics can teach us about malaria.

Authors:  Dominic P Kwiatkowski
Journal:  Am J Hum Genet       Date:  2005-07-06       Impact factor: 11.025

2.  Changing patterns of Plasmodium blood-stage infections in the Wosera region of Papua New Guinea monitored by light microscopy and high throughput PCR diagnosis.

Authors:  Laurin J Kasehagen; Ivo Mueller; David T McNamara; Moses J Bockarie; Benson Kiniboro; Lawrence Rare; Kerry Lorry; Will Kastens; John C Reeder; James W Kazura; Peter A Zimmerman
Journal:  Am J Trop Med Hyg       Date:  2006-10       Impact factor: 2.345

3.  Minimal association of common red blood cell polymorphisms with Plasmodium falciparum infection and uncomplicated malaria in Papua New Guinean school children.

Authors:  Enmoore Lin; Livingstone Tavul; Pascal Michon; Jack S Richards; Elijah Dabod; James G Beeson; Christopher L King; Peter A Zimmerman; Ivo Mueller
Journal:  Am J Trop Med Hyg       Date:  2010-10       Impact factor: 2.345

Review 4.  Blood Groups in Infection and Host Susceptibility.

Authors:  Laura Cooling
Journal:  Clin Microbiol Rev       Date:  2015-07       Impact factor: 26.132

5.  Using mutagenesis and structural biology to map the binding site for the Plasmodium falciparum merozoite protein PfRh4 on the human immune adherence receptor.

Authors:  Hyon Ju Park; Mara Guariento; Mateusz Maciejewski; Richard Hauhart; Wai-Hong Tham; Alan F Cowman; Christoph Q Schmidt; Haydyn D T Mertens; M Kathryn Liszewski; Dennis E Hourcade; Paul N Barlow; John P Atkinson
Journal:  J Biol Chem       Date:  2013-11-08       Impact factor: 5.157

6.  A preliminary assessment of Toll-like receptor and β-defensin gene polymorphisms in Papua New Guinea - what does it mean for HIV/AIDS?

Authors:  Barne Willie; Janet Gare; Christopher L King; Peter A Zimmerman; Rajeev K Mehlotra
Journal:  P N G Med J       Date:  2017 Mar-Jun

7.  Population hemoglobin mean and anemia prevalence in Papua New Guinea: new metrics for defining malaria endemicity?

Authors:  Nicolas Senn; Seri Maraga; Albert Sie; Stephen J Rogerson; John C Reeder; Peter Siba; Ivo Mueller
Journal:  PLoS One       Date:  2010-02-24       Impact factor: 3.240

Review 8.  Blood groups and malaria: fresh insights into pathogenesis and identification of targets for intervention.

Authors:  J Alexandra Rowe; D Herbert Opi; Thomas N Williams
Journal:  Curr Opin Hematol       Date:  2009-11       Impact factor: 3.284

9.  Diagnosing infection levels of four human malaria parasite species by a polymerase chain reaction/ligase detection reaction fluorescent microsphere-based assay.

Authors:  David T McNamara; Laurin J Kasehagen; Brian T Grimberg; Jennifer Cole-Tobian; William E Collins; Peter A Zimmerman
Journal:  Am J Trop Med Hyg       Date:  2006-03       Impact factor: 2.345

10.  Molecular evolution of GYPC: evidence for recent structural innovation and positive selection in humans.

Authors:  Jason A Wilder; Elizabeth K Hewett; Meredith E Gansner
Journal:  Mol Biol Evol       Date:  2009-08-13       Impact factor: 16.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.